Yiting Sun

970 total citations
41 papers, 680 citations indexed

About

Yiting Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yiting Sun has authored 41 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Yiting Sun's work include Cancer Immunotherapy and Biomarkers (7 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yiting Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yiting Sun collaborates with scholars based in China, United States and Taiwan. Yiting Sun's co-authors include Zeyi Zhao, Lian Liu, Li Song, Chengyu Jiang, Fengzhu Guo, X. Johné Liu, Guigen Zhang, Yuechao Zhao, Peng Yang and HL Liu and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Yiting Sun

35 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiting Sun China 14 235 172 119 118 110 41 680
Wenjing Zhang China 18 447 1.9× 140 0.8× 138 1.2× 154 1.3× 200 1.8× 47 956
Xiangqi Chen China 17 513 2.2× 136 0.8× 79 0.7× 117 1.0× 173 1.6× 60 946
Yeon‐Mi Ryu South Korea 14 238 1.0× 190 1.1× 67 0.6× 82 0.7× 67 0.6× 29 602
Yanqi He China 20 370 1.6× 190 1.1× 70 0.6× 149 1.3× 182 1.7× 47 875
Jiacheng Li China 17 284 1.2× 97 0.6× 104 0.9× 113 1.0× 91 0.8× 93 845
Kaiwen Hu China 14 260 1.1× 186 1.1× 56 0.5× 153 1.3× 146 1.3× 78 892
Jingjun Huang China 17 208 0.9× 148 0.9× 83 0.7× 111 0.9× 139 1.3× 36 916
Jingyu Cao China 16 357 1.5× 138 0.8× 78 0.7× 87 0.7× 111 1.0× 62 773
Aslam A. Khan United States 15 297 1.3× 129 0.8× 158 1.3× 96 0.8× 96 0.9× 29 1.2k
Shujun Xia China 19 350 1.5× 164 1.0× 76 0.6× 49 0.4× 157 1.4× 56 871

Countries citing papers authored by Yiting Sun

Since Specialization
Citations

This map shows the geographic impact of Yiting Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiting Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiting Sun more than expected).

Fields of papers citing papers by Yiting Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiting Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiting Sun. The network helps show where Yiting Sun may publish in the future.

Co-authorship network of co-authors of Yiting Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yiting Sun. A scholar is included among the top collaborators of Yiting Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiting Sun. Yiting Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Sun, Yiting, Bowen Yang, Ti Wen, et al.. (2025). ANXA10 sensitizes microsatellite instability-high colorectal cancer to anti-PD-1 immunotherapy via assembly of HLA-DR dimers by regulating CD74. Cell Biology and Toxicology. 41(1). 25–25.
4.
Jia, Yu, et al.. (2024). A novel Zn(II) coordination polymer based on viologen: Photochromism, photocontrolled luminescence, ammonia vapor sensing, and luminescent sensing. Inorganic Chemistry Communications. 170. 113239–113239. 9 indexed citations
5.
Sun, Yiting, et al.. (2024). Novel insights into the interaction between IGF2BPs and ncRNAs in cancers. Cancer Cell International. 24(1). 437–437. 2 indexed citations
6.
Sun, Yiting, et al.. (2024). An expert system for species discrimination and grade identification of fish maw. Microchemical Journal. 207. 112141–112141. 2 indexed citations
7.
Sun, Yiting & Jorge Ruiz. (2023). Home made vegan nuggets with texturized soy protein and tempeh as compared to chicken-based ones: Texture, consumer perception and environmental impact. International Journal of Gastronomy and Food Science. 33. 100748–100748. 5 indexed citations
8.
9.
Chen, Jie, Ying Xie, Yiting Sun, et al.. (2023). Life-course inequalities in intrinsic capacity and healthy ageing, China. Bulletin of the World Health Organization. 101(5). 317–325A. 1 indexed citations
10.
Wang, Xin, Hua Bai, Jiyang Zhang, et al.. (2023). Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer. Journal of Thoracic Oncology. 19(2). 252–272. 16 indexed citations
11.
Sun, Yiting, Hua Bai, Jianchun Duan, et al.. (2022). Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization. EBioMedicine. 83. 104200–104200. 23 indexed citations
12.
Liu, Lihui, Hua Bai, Chao Wang, et al.. (2021). Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis. Journal of Thoracic Oncology. 16(7). 1099–1117. 92 indexed citations
13.
Sun, Yiting, Liqing Jiang, Ti Wen, et al.. (2021). Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study. Frontiers in Pharmacology. 12. 670900–670900. 11 indexed citations
14.
Sun, Yiting, Li Song, Wenbin Yu, et al.. (2020). CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR. Journal of Cancer. 11(9). 2667–2678. 10 indexed citations
15.
Sun, Yiting, et al.. (2020). TARDIS: Rolling Back The Clock On CMS-Targeting Cyber Attacks. 1156–1171. 7 indexed citations
16.
Sun, Yiting, Li Song, Wenbin Yu, et al.. (2020). N6-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death and Disease. 11(10). 836–836. 63 indexed citations
17.
Zhang, Di, Li Song, Wenbin Yu, et al.. (2018). LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1. Cancer Management and Research. Volume 10. 4349–4361. 9 indexed citations
18.
Sun, Yiting, Wei Sun, Li Yao, et al.. (2016). Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis. Scientific Reports. 6(1). 39346–39346. 19 indexed citations
19.
Hung, Wei‐Chin, et al.. (2016). Comparative Study of the Condensing Effects of Ergosterol and Cholesterol. Biophysical Journal. 110(9). 2026–2033. 31 indexed citations
20.
Liu, HL, YL Zhang, Ning Yang, et al.. (2011). A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt–TSC2-mTOR signaling. Cell Death and Disease. 2(5). e159–e159. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026